SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Ongoing pharmaceutical reforms in France · Study

ArticleShelves

ArticleOngoing pharmaceutical reforms in France

Catherine Sermet2010

Article2010

Ongoing pharmaceutical reforms in France

Catherine Sermet · Veronique Andrieu · Brian Godman · Eric H. Van Ganse · Alan R Haycox · Jean‐Pierre Reynier

108 citations·0/0 files stored·Applied Health Economics and Health Policy

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Pharmaceutical Economics and Policy Healthcare Systems and Reforms Health Systems, Economic Evaluations, Quality of Life

Abstract

No abstract was published for this record.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 108 citations exist upstream.

References

2009Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance 2013Estonia: Health System Review.

Cited by

2009Soft regulations in pharmaceutical policy making 2012Ongoing measures to enhance the efficiency of prescribing of proton pump inhibitors and statins in The Netherlands: influence and future implications 2010Use of Generics—A Critical Cost Containment Measure for All Healthcare Professionals in Europe?2015Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review 2012International Variability in the Reimbursement of Cancer Drugs by Publically Funded Drug Programs 2013Demand-side policies to encourage the use of generic medicines: an overview 2013Reforms and initiatives in Scotland in recent years to encourage the prescribing of generic drugs, their influence and implications for other countries 2011Does the Market Share of Generic Medicines Influence the Price Level?

Related works

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

2022The burden of mental health-related mortality in the Baltic States in 2007-2018article · 1 shared reference 2014Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?review · 1 shared reference 2011Policies to Enhance Prescribing Efficiency in Europe: Findings and Future Implicationsarticle · 1 shared reference 2017High adherence to the ‘Wise List’ treatment recommendations in Stockholm: a 15-year retrospective review of a multifaceted approach promoting rational use of medicinesarticle · 1 shared reference 2009Soft regulations in pharmaceutical policy makingarticle · 1 shared reference 2012Ongoing measures to enhance the efficiency of prescribing of proton pump inhibitors and statins in The Netherlands: influence and future implicationsarticle · 1 shared reference

Details

Year2010

Typearticle

Published2010-01-01

VenueApplied Health Economics and Health Policy

ISSN-L1175-5652

Languageen

Citations108

Files0 public / 0

ShelfPharmaceutical Economics and Policy

Identifiers

doi10.1007/bf03256162

openalex_workW182852820

Links

Imported from OpenAlex (CC0) — nothing here is generated.